On the HCPLive news page, resources on the topics of disease- and specialty-specific medical news and expert insight can be found. Content includes articles, interviews, videos, podcasts, and breaking news on health care research, treatment, and drug development.
CDC: "No Way to Get Ebola Risk to Zero"
As concern mounts about the possibility of Ebola spreading throughout the US, hospitals are increasingly vigilant. At a news briefing Oct.13, CDC director Thomas Frieden, MD, said the agency has not changed its mind about not restricting travel to and from West Africa, and is focused on tightening infection control measures to "break the chain of infection." The CDC still has not learned how a nurse who cared for Dallas, TX, Ebola victim Thomas Eric Duncan got infected, but perhaps it was her gloves, Frieden suggested. Testing takes time, doctors elsewhere report.
Nancy Snyderman, MD, a medical editor for NBC news is under a New Jersey State Department of Health quarantine after www.PlanetPrinceton.com reported that she was violating an agreement to stay at home. Snyderman, a Princeton, NJ resident, may have been exposed to Ebola during a trip to Liberia. Celebrity watching in Princeton, NJ is usually a low-key affair. Not this time, Snyderman learned.
FDA Approves Hepatitis C Combo Drug
The US Food and Drug Administration (FDA) on Oct. 10 approved a new drug combining ledipasvir and sofosbuvir (Harvoni/Gilead) as a treatment for chronic hepatitis C virus (HCV) infection. The approval is the third drug approved for chronic HCV in the past year. The others are simeprevir (Olysio/Janssen) and sofosbuvir (Sovaldi/Gilead).
Finding Unlocks Neurogenesis Mystery
Neurogenesis does not happen much in healthy brains, but it does after a stroke. In a mouse study, a Swedish team has determined how that happens. Their discovery could hold promise for regenerating neurons for many conditions. Reporting in Science , Jens Magnusson and colleagues called their finding "potentially useful for neuronal replacement strategies."
No Ebola in Second Suspected Case
As friends and family mourned Ebola victim Thomas Eric Duncan, there was some good news. Ebola tests done on a Dallas County Sherrif's deputy came back negative. The Texas State Department of Health made the announcement Oct. 9. The patient, identified as Michael Monnig, had briefly visited the apartment where Duncan was staying and on Oct. 8 was admitted to the hospital where Duncan died, Texas Health Presbyterian.
Animal lovers expressed outrage Oct. 8 as health officials in Spain made good on their pledge to euthanize the 12-year-old pet dog of a woman known to have the Ebola virus. But a research study published in Emerging Infectious Diseases in 2005 documented that many dogs in Africa that lived in neighborhoods where the virus was prevalent showed signs they were carrying the virus. The CDC supplied the Ebola tests for that research.
Doctors who treated Ebola patient Thomas Eric Duncan, the 42-year-old Liberian man who died in Dallas Oct. 8, likely missed their window of opportunity. "It's hard to say exactly what happened, but they sent him home and he came back later-and with Ebola, the earlier the treatment, the better," said Sanjay Gupta, MD, head of the emergency department at Franklin Hospital in Valley Stream, NY.
Obese Children Have Heart Damage
Heart trouble can start early for obese children, a German research team found. Writing in the Journal of the American College of Cardiology, Norman Manger, MD, and colleagues compared blood pressure, low-density lipoprotein cholesterol, and glucose metabolism in 61 obese children with that of 40 children with healthy weights. The obese group had an average BMI of about 31 while the control group's average BMI was about 20.
USPSTF Seeks Public Input on Screening Guidelines
The US Preventive Services Task Force (USPSTF) recently released a draft version of screening recommendations for abnormal glucose and type 2 diabetes mellitus in adults who are at increased risk for diabetes, and is seeking public input on the suggestions.
First US Ebola Patient Dies While Suspected Patient Released
The first person in the United States to be diagnosed with the Ebola virus died on Wednesday morning according to multiple media reports, while another patient suspected of having Ebola was released from the hospital.
Non-Cardiac Surgery in Adult Congenital Heart Disease: Not Child's Play
October 8th 2014Study results show that the majority of adult patients with congenital heart disease and their clinicians ignore American College of Cardiology and American Heart Association recommendations that any non-cardiac surgery for these patients should be performed in regionalized centers of expertise.
Making Bariatric Surgery Available to More Patients and Identifying Those Likely to Benefit the Most
October 8th 2014Researchers compared outcomes from bariatric surgery with those achieved through medical weight management in patients with diabetes to determine the effectiveness of bariatric surgery in patients with BMI less than 35. They also evaluated a potential biomarker for identifying patients likely to experience the best surgical outcomes.
Masculine Facial Features, Testosterone Levels, and Social Selection
Do women prefer the sort of masculine faces that indicate high testosterone levels? New research suggests that the answer may depend upon where you live, but if you live in an advanced market economy, the answer is probably "yes."
Will the FDA Tighten the Use of Testosterone Replacement Therapy?
A recommendation by two FDA advisory panels to narrow the official approval for testosterone replacement therapy has won generally favorable reviews from medical organizations, although questions remain about its ultimate impact.
As part of federal efforts to curb prescription drug abuse, the US Drug Enforcement Agency (DEA) is reclassifying hydrocodone-combination drugs (Vicodin/AbbVie) as a schedule 2 controlled substance. But even if the tighter controls mean some doctors will switch appropriate patients to schedule 3 drugs, like acetaminophen with codeine, alternative painkillers have a long way to go to topple the market leader, according to data from IMS Health.